Alfaras, Andrea Ellize B.
HRN: 24-40-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
CEFUROXIME 750MG (VIAL)
01/09/2024
01/16/2024
IV
750mg
Q8h
For OR
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes